109 completed, 12 unknown, 6 terminated, 5 withdrawn. 143 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 143 | Completed 109, Unknown 12, Terminated 6, Withdrawn 5, Active not recruiting 3, Not yet recruiting 3, Recruiting 3, Suspended 2 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Timed Aspirin Chronobiome Study Aspirin 81 mg, Celecoxib 200mg capsule - Healthy | Early Phase 1 | Not yet recruiting | University of Pennsylvania | 60 | 2027-12-01 | 2026-05-29 |
| Research Investigating Drug Effects-2 (RiDE-2) Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD) | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 144 | 2027-01-04 | 2026-10-22 |
| PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study) 64Cu-NODAGA-CANF - Healthy Adult, Healthy | Early Phase 1 | Recruiting | Washington University School of Medicine | 8 | 2026-08-19 | 2026-09-02 |
| Topical Tartrazine for Improved Skin Structure Visualization in Dermatology Four-Chamber Tartrazine Patch across 3 Body Sites - Healthy, Dermoscopy | Early Phase 1 | Withdrawn | Johns Hopkins University | 2026-05-11 | 2025-11-14 | |
| Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors Assist, Resist, Slack - Healthy | Early Phase 1 | Not yet recruiting | Shirley Ryan AbilityLab | 20 | 2026-01-31 | 2025-07-30 |
| Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol [18F]-fluoromannitol - Healthy | Early Phase 1 | Active not recruiting | St. Jude Children's Research Hospital | 11 | 2025-09-17 | 2026-08-21 |
| A Study of IBI3032 in Chinese Healthy Subjects placebo, IBI3032 - Healthy | Early Phase 1 | Completed | Innovent Biologics Technology Limited (Shanghai R&D Center) | 40 | 2025-08-29 | 2025-11-17 |
| Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults Shoden - Healthy, Aging | Early Phase 1 | Withdrawn | Oregon Health and Science University | 2025-07-01 | 2025-12-17 | |
| Acute Intervention with Sulforaphane-Smart® Sulforaphan Smart® - Healthy | Early Phase 1 | Unknown | Mª Jesús Periago | 20 | 2025-03-01 | 2025-03-04 |
| Topical Tripelennamine 1% Cream Versus Diphenhydramine 1% Cream for the Relief of Histamine-Induced Itching: A Proof Concept Study in Healthy Adults. Tripelennamine, Diphenhydramine, Vehicle Control Cream Base - Healthy | Early Phase 1 | Completed | Palm Beach Atlantic University | 37 | 2025-02-24 | 2026-08-21 |
| A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers DPH001, Nexavar (Sorafenib) - Healthy | Early Phase 1 | Completed | Disruptive Pharma | 12 | 2025-02-10 | 2025-03-17 |
| Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers V-212 (or Placebo) administered by i.m injection (3 vaccinations) - low dose, V-212 (or Placebo) administered by i.m injection (3 vaccinations) - medium dose, V-212 (or Placebo) administered by i.m injection (3 vaccinations) - high dose - Healthy, Immunisation Against Streptococcus Pneumoniae | Early Phase 1 | Completed | Virometix | 60 | 2025-01-29 | 2026-08-20 |
| Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration Testosterone injection, Testosterone gel, Testosterone Oral - Healthy | Early Phase 1 | Completed | Sports Medicine Research and Testing Laboratory | 14 | 2024-11-27 | 2024-12-03 |
| Study on the Relationship Between Indoor Environment, Use of Personal Disinfection Products, and Human Health Quaternary Ammonium Compound Disinfectants, Alcohol-based Disinfectants - Healthy | Early Phase 1 | Active not recruiting | National Natural Science Foundation of China | 64 | 2024-10-01 | 2026-08-12 |
| Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent [11C]MeDAS - Healthy | Early Phase 1 | Withdrawn | Robert Fox | 2024-07-24 | 2025-02-17 | |
| Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study CoQ10 - Crohn Disease, Healthy | Early Phase 1 | Active not recruiting | University of Pennsylvania | 60 | 2024-07-20 | 2026-10-09 |
| AGED Diagnostics Liver Disease Assessment AGED Multiple Target Assay in Healthy Controls, AGED Multiple Target Assay in NAFLD Participants, AGED Multiple Target Assay in Fibrosis Participants - NASH With Fibrosis, NAFLD | Early Phase 1 | Unknown | Active Genomes Expressed Diagnostics, Corp | 400 | 2024-05-15 | 2024-04-04 |
| Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease Caffeine Pill, Placebo, TASSO+ Device - Healthy | Early Phase 1 | Unknown | Hamilton Health Sciences Corporation | 36 | 2024-04-08 | 2024-04-11 |
| Ashwagandha Pharmacokinetics Study in Older Adults Shoden - Healthy, Aging | Early Phase 1 | Terminated | Oregon Health and Science University | 11 | 2024-04-08 | 2026-04-09 |
| A Study of Perturbation of Human Small Intestinal Colonic Permeability Ricinoleic Acid 750 mg, Ricinoleic Acid 1500 mg, Ricinoleic Acid 3000 mg - Healthy | Early Phase 1 | Completed | Mayo Clinic | 24 | 2024-01-08 | 2024-09-19 |
Showing 20 of 143. Sign in to see all of them.
Aneurysm (4) · Alzheimer Disease (3) · Insulin Resistance (3) · Marijuana Abuse (3) · Obesity (3) · Psychotic Disorders (3) · Atherosclerosis (2) · Substance-Related Disorders (2) · Asthma (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Blister (1) · Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1)
Mental Disorders (13) · Pathological Conditions, Signs and Symptoms (12) · Nervous System Diseases (9) · Signs and Symptoms (8) · Chemically-Induced Disorders (6) · Nutritional and Metabolic Diseases (6) · Vascular Diseases (6) · Cardiovascular Diseases (5) · Metabolic Diseases (4) · Neurologic Manifestations (4) · Pathologic Processes (4) · Respiratory Tract Diseases (4) · Substance-Related Disorders (4) · Body Weight (3) · Brain Diseases (3)
Oxytocin (7) · Dronabinol (6) · Lysergic Acid Diethylamide (5) · Magnetic Resonance Spectroscopy (5) · N-Methyl-3,4-methylenedioxyamphetamine (4) · Aspirin (3) · Cannabidiol (3) · Glucose (3) · Insulin (3) · Indomethacin (2) · Inulin (2) · Tablets (2) · (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine (1) · 1-((3-(methylpyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one (1) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)
University Hospital, Basel, Switzerland (7) · Yale University (7) · Janssen Research & Development, LLC (6) · University of Electronic Science and Technology of China (6) · University of Missouri-Columbia (5) · Lyndra Inc. (3) · Oregon Health and Science University (3) · University of Chicago (3) · University of Pennsylvania (3) · University of Zurich (3) · Beth Israel Deaconess Medical Center (2) · Castleton University (2) · Charite University, Berlin, Germany (2) · Massachusetts General Hospital (2) · Mayo Clinic (2)
United States (74) · Switzerland (10) · China (9) · Belgium (7) · Germany (7) · Canada (6) · United Kingdom (5) · Australia (4) · Netherlands (3) · Brazil (2) · Denmark (2) · Israel (2) · Sweden (2) · Finland (1) · France (1)
Matthias E Liechti, MD, MAS (7) · Keith Kendrick, Dr. (3) · Alex Speers, ND (2) · Harriet de Wit (2) · Jacqueline K Limberg, Ph.D. (2) · Keith Kendrick, PhD (2) · Michael Camilleri, MD (2) · Mohini Ranganathan, MD (2) · Sepehr Shakib, MD (2) · Ahmed El-Sohemy, PhD (1) · Alexander Swidsinski, Doctor (1) · Amala Soumyanath, PhD (1) · Andre Crouch, MD (1)
PMID 27249781, PMID 27714429, PMID 28197931, PMID 28566523, PMID 20676081, PMID 22174728, PMID 23592479, PMID 25398084, PMID 25453395, PMID 25466258, PMID 25575620, PMID 25695490, PMID 25900275, PMID 26249791, PMID 27206648, PMID 27322029, PMID 27330024, PMID 27605407, PMID 28097231, PMID 28375205, PMID 28551715, PMID 28656110, PMID 28874545, PMID 28918441, PMID 29884456, PMID 29912955, PMID 31668830, PMID 31706582, PMID 33420913, PMID 35086102, PMID 35217796, PMID 35319274, PMID 35573309, PMID 35910354, PMID 36507738, PMID 37253044, PMID 39236186, PMID 40525591
2019 (2), KL2TR002370 (2), 2017 (1), 3OT2OD023867-01S2 (1), K01MH109871 (1), K23DA048132 (1), K99HL130339 (1), P01HL131478 (1), R00HL130339 (1), R01DA054314 (1), R01HL159803 (1), R21AT004236 (1), R21DA042633 (1), R44MH116764 (1), U19AI082639 (1)